Refeyn, a leading life science instrumentation company pioneering mass photometry, announced today that Dr. Susan Altschuller has been appointed a Non-Executive Director of Refeyn, effective October 1st, 2025. Dr. Susan Altschuller Chief Financial Officer of Climb Bio, Inc. Dr. Susan Altschuller is a seasoned biotechnology executive with over two decades of experience in the life […]
Natalia Markova New to Refeyn’s Scientific Advisory Board Refeyn is pleased to announce that Natalia Markova has joined its Scientific Advisory Board (SAB). With a genuine interest in the design and application of label-free biophysical technologies sparked during her PhD at Lund University, Natalia has built a career advancing microcalorimetry, biosensors, and particle characterization tools […]
Adenoviral vectors (AdV) are widely used as effective delivery platforms for vaccines, gene therapies and cancer treatments. In order to ensure these therapeutic products are safe and effective, critical quality attributes (CQA) of samples like their purity and stability need to be appropriately assessed frequently during production. This creates an analytical bottleneck, as current methodologies […]
Antibodies are powerful therapeutics used to treat a range of diseases, which is being expanded thanks to the development of new engineered formats like bispecifics. However, developing new antibodies comes with significant analytical challenges: Antigens used for antibody development need to be characterized to ensure they are pure and have the desired oligomeric state Antibody […]
Adeno‐associated viruses (AAVs) are small, non-pathogenic viruses commonly used as vehicles for gene-therapy delivery. With an increasing number of clinical studies and success stories in the treatment of genetic disorders, AAVs continue to drive advances in the field. To support the development and production of AAV therapies, there is a need for efficient purification techniques. […]
Explore how mass photometry compares to traditional pre-screening tools—and how recent studies reveal its growing role and applications in pre-cryo-EM workflows. The impact of cryo-electron microscopy (cryo-EM) on structural biology has been transformational. Recognized with the Nobel Prize in Chemistry in 2017, cryo-EM has opened the door to atomic-level insights into some of the most […]
USP employs mass photometry as key orthogonal method for empty/full characterization of AAV capsids Refeyn’s SamuxMP mass photometer for AAV analytics – used for characterizing the U.S. Pharmacopeia’s new adeno-associated virus (AAV) reference standards. Oxford, UK (18 June, 2025) – Refeyn announces that mass photometry has been recognized by the U.S. Pharmacopeia (USP)—and referenced in […]
Oxford, UK – 10 June 2025 – Refeyn, a leader in mass photometry and analytical instrumentation, today announced that Jonathan Flint is stepping down as Chairman of the Board of Directors after completing two successful three-year terms. Flint’s tenure has been marked by significant growth and innovation, and the company extends its deepest gratitude for his […]
Refeyn’s TwoMP mass photometer and MassFluidix HC system newly installed at the University of Copenhagen in action with Dr. Anni Kumari. Oxford, UK (07 May, 2025) – Refeyn, the company behind pioneering mass photometry technology, has announced the installation of the 500th system based on its novel single-particle bioanalytical technology – notably, within just seven […]
Mass photometry measures the mass of single particles in solution without disruptive preparation or labels. This powerful simplicity makes it a versatile technique, with a role to play in a variety of applications, from assessing antibody aggregation to measuring RNA length. Among these, characterizing AAVs is one where mass photometry really shines and is quickly […]
